Andrew Cavey

Andrew Cavey serves as Chief Executive Officer at ITM Isotope Technologies Munich SE. ITM Isotope Technologies Munich SE operates in the pharmaceuticals sector with approximately 530.0 employees. The company is headquartered in Basel, Basel-Stadt. ITM Isotope Technologies Munich SE generates annual revenue of 15000000.0. To date, ITM Isotope Technologies Munich SE has raised 692083190.0 in total funding, with the most recent round being Other.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 259 executive contacts are available in Basel-Stadt.
• • Our database includes 201,469 c suite-level executives.

Outlook TYPO3 Mobile Friendly Bootstrap Framework Apache SAP Qlik Sense

theranostic radioisotope platform technologies global network to guarantee security of supply strategic alliances in order to further develop theranostics driving force to establish global standards regarding safety & efficacy of radiopharmaceuticals pharmaceutical manufacturing radiopharmaceuticals clinical trials precision oncology radiolabeling gmp radiolabeling service medical radioisotopes therapeutic isotopes targeted radionuclide therapy dual-action treatments non-carrier added lutetium-177 actinium-225 endolucinbeta tocscan theranostics diagnostic radiopharmaceuticals improved patient outcomes neuroendocrine tumors glioblastoma treatment prostate cancer therapy ovarian cancer treatment supply agreements pipeline therapy expanded access programs quality control equipment biotech partnerships global supply network patient-centric approach adenocarcinoma n.c.a. 177lu labeling clinical diagnostics oncology research innovative treatments scientific publications therapeutic radioisotopes compliance in production preclinical studies clinical studies fda approvals cancer diagnostics pharmaceutical development radiopharmaceutical biomarkers collaboration agreements reagents for synthesis advanced cancer therapies multifaceted oncology solutions evidence-based treatments biotechnology cancer therapeutics radioisotopes lutetium-177 clinical development phase iii studies radiochemistry gmp radiolabeling radiation safety quality control patient care unmet medical needs global supply cancer treatment advanced diagnostics targeted therapies clinical outcomes patient quality of life oncology market vertical integration research & development collaboration precision medicine pharmaceuticals medical health care health wellness & fitness hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

How can I contact Andrew Cavey?

Andrew Cavey's verified email address is available on MessageCEO. They currently work at ITM Isotope Technologies Munich SE. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Andrew Cavey lead?

Andrew Cavey is Chief Executive Officer at ITM Isotope Technologies Munich SE, a company in the pharmaceuticals sector with 530.0 employees. The company is based in Basel, Basel-Stadt.

What industry is Andrew Cavey in?

Andrew Cavey works in the pharmaceuticals industry as Chief Executive Officer at ITM Isotope Technologies Munich SE. MessageCEO provides verified contact information for executives across all major industries.

Is Andrew Cavey's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Andrew Cavey's profile is kept up-to-date with the latest available information.

Last updated: April 9, 2026